ClinicalTrials.gg
CompletedNCT00893243Updated May 5, 2009

Efficacy Comparative Study Between Tears Again®, Opticol® and Optive®

An observational study in Dry Eye Syndrome, sponsored by Hospital de Sao Sebastiao. Completed at 1 site in Portugal. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-05-05.

Sponsored by Hospital de Sao Sebastiao · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
27
Ages
18 Years to 55 Years
Sex
All
01

Study summary

Primary Purpose:

  • To compare the efficacy in treating dry eye syndrome in contact lens wearers or computer users of Tears Again® versus Opticol® versus Optive®

Secondary Purpose:

  • Subjective evaluation of symptomatology
  • Evaluation of preference in different kind of administration - spray versus monodoses versus multi-doses
02

Conditions studied

  • Dry Eye Syndrome

Browse trials for

03

In context

Dry Eye Syndromes

1,370 studies on the registry are indexed under Dry Eye Syndromes; 209 are open to participants now.

This study's enrollment of 27 is below the median of 88 across 191 observational studies indexed under Dry Eye Syndromes.

Browse Dry Eye Syndromes studies →

Lead sponsor

Hospital de Sao Sebastiao is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Administrative staff of the hospital with more than 4 hours/day computer use and contact lens wearers

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • signed
  • Age >18 years and \< 55 years
  • Daily wearer of soft contact lens and/or daily (> 4 hours/day) computer user

Exclusion criteria

Exclusion Criteria:

  • Dry eye Syndrome other than of evaporative etiology, according to DEWS
  • Ocular or systemic disease that can affect the normal tear film
  • Pregnancy or pregnancy risk (no method), lactation
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
27 participants (actual)

Groups and cohorts

  • 1Tears Again/Control
  • 2Opticol/Control
  • 3Optive/Control
  • 4Tears Again/Opticol
  • 5Tears Again/Optive
  • 6Opticol/Optive
06

Study locations

1 site
  • Serviço de Oftalmologia, Hospital de São Sebastião
    Santa maria da Feira, 4520-211, Portugal
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 5, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00893243
Lead sponsor
Hospital de Sao Sebastiao
First posted
May 5, 2009
Last update
May 5, 2009

Study contacts

Lilianne Duarte, MD
principal investigator · Ophthalmologist
José Salgado-Borges, PhD
study director · Ophthalmology Department Director

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion